To assess the diagnostic performance of a new method for quick detection of tuberculosis and its resistance to anti TB drugs like rifampicin and isoniazid
Phase 2
- Conditions
- Health Condition 1: A150- Tuberculosis of lung
- Registration Number
- CTRI/2019/09/021240
- Lead Sponsor
- Foundation for Innovative New Diagnostics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Aged 18 years or more
Clinical suspicion of pulmonary TB including cough >=2 weeks and any other symptom typical of pulmonary TB listed below
Fever
Malaise
Recent weight loss
Night sweats
Contact with active case
Haemoptysis
Chest pain
Loss of appetite
Exclusion Criteria
Unwilling or unable to provide informed consent
Unwilling to provide two sputum specimens at enrolment
Patients with only extra-pulmonary TB signs & symptoms
Receipt of any dose of TB treatment within 6 months prior to enrolment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method